Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers

Published:2017-07-18 Issue:6 Volume:117 Page:826-834
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Klimov Sergey,Rida Padmashree CG,Aleskandarany Mohammed A,Green Andrew R,Ellis Ian O,Janssen Emiel AM,Rakha Emad A,Aneja Ritu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2017224.pdf

Reference82 articles.

1. Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116 (3): 340–350.

2. Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO (2004) Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203 (2): 661–671.

3. Abduljabbar R, Negm OH, Lai CF, Jerjees DA, Al-Kaabi M, Hamed MR, Tighe PJ, Buluwela L, Mukherjee A, Green AR, Ali S, Rakha EA, Ellis IO (2015) Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer. Breast Cancer Res Treat 150 (2): 335–346.

4. Aleskandarany MA, Negm OH, Green AR, Ahmed MA, Nolan CC, Tighe PJ, Ellis IO, Rakha EA (2014) Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study. Breast Cancer Res Treat 145 (2): 339–348.

5. Alshareeda AT, Negm OH, Green AR, Nolan CC, Tighe P, Albarakati N, Sultana R, Madhusudan S, Ellis IO, Rakha EA (2015) KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer. Br J Cancer 112 (12): 1929–1937.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IF-7 and GALA modified PEG-PDMAEMA loaded SOX10 siRNA nanoparticles: Preparation, cellular delivery, and inhibition on progression of triple negative breast cancer and its bone metastasis in vitro;Journal of Drug Delivery Science and Technology;2024-10

2. ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells;Experimental Hematology & Oncology;2023-12-10

3. Risk of metastasis in BRCA2 carriers diagnosed with triple‐negative breast cancer;Cancer Medicine;2023-07-23

4. Development and external validation of a prediction model for brain metastases in patients with metastatic breast cancer;Journal of Cancer Research and Clinical Oncology;2023-07-11

5. Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities;Frontiers in Molecular Biosciences;2022-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3